Hochschulschrift
Multiplex in vitro and in vivo RNAi screening to identify treatment response modifiers of targeted therapies in HCC
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
30 cm
- Extent
-
124 S.
- Language
-
Englisch
- Notes
-
Ill., graph. Darst.
Braunschweig, Techn. Univ., Diss., 2014
- Classification
-
Medizin, Gesundheit
Biowissenschaften, Biologie
- Creator
-
Rudalska, Ramona Paulina
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.06.2025, 1:33 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
- Rudalska, Ramona Paulina
Other Objects (12)
Multiplex in vitro and in vivo RNAi screening to identify treatment response modifiers of targeted therapies in HCC
Novel RNAi-Based Therapies for Atherosclerosis
Modifiers of notch transcriptional activity identified by genome-wide RNAi
A Genome-Wide RNAi Screen for Modifiers of Polyglutamine-Induced Neurotoxicity in Drosophila
Identification of modifiers of cellular viability and TRAIL-induced apoptosis using genome-wide RNAi screens
A large-scale RNAi-based screen for modifiers of FUS-induced neurotoxicity in Drosophila melanogaster
A Genome-Wide Screen on Modifiers of Tau-Induced Neurodegeneration Using RNAi-Mediated Gene Silencing in Drosophila
RNAi to treat SARS‐CoV‐2—variant proofing the next generation of therapies
Lipid Nanoparticle (LNP) ‐A Vector Suitable for Evolving Therapies for Advanced Hepatocellular Carcinoma (HCC)
HccB
HccB
HccB"
Multiplex in vitro and in vivo RNAi screening to identify treatment response modifiers of targeted therapies in HCC
Novel RNAi-Based Therapies for Atherosclerosis
Modifiers of notch transcriptional activity identified by genome-wide RNAi
A Genome-Wide RNAi Screen for Modifiers of Polyglutamine-Induced Neurotoxicity in Drosophila
Identification of modifiers of cellular viability and TRAIL-induced apoptosis using genome-wide RNAi screens
A large-scale RNAi-based screen for modifiers of FUS-induced neurotoxicity in Drosophila melanogaster
A Genome-Wide Screen on Modifiers of Tau-Induced Neurodegeneration Using RNAi-Mediated Gene Silencing in Drosophila
RNAi to treat SARS‐CoV‐2—variant proofing the next generation of therapies
Lipid Nanoparticle (LNP) ‐A Vector Suitable for Evolving Therapies for Advanced Hepatocellular Carcinoma (HCC)
HccB
HccB
HccB"
Multiplex in vitro and in vivo RNAi screening to identify treatment response modifiers of targeted therapies in HCC
Novel RNAi-Based Therapies for Atherosclerosis
Modifiers of notch transcriptional activity identified by genome-wide RNAi
A Genome-Wide RNAi Screen for Modifiers of Polyglutamine-Induced Neurotoxicity in Drosophila
Identification of modifiers of cellular viability and TRAIL-induced apoptosis using genome-wide RNAi screens
A large-scale RNAi-based screen for modifiers of FUS-induced neurotoxicity in Drosophila melanogaster
A Genome-Wide Screen on Modifiers of Tau-Induced Neurodegeneration Using RNAi-Mediated Gene Silencing in Drosophila
RNAi to treat SARS‐CoV‐2—variant proofing the next generation of therapies
Lipid Nanoparticle (LNP) ‐A Vector Suitable for Evolving Therapies for Advanced Hepatocellular Carcinoma (HCC)
HccB
HccB